180 related articles for article (PubMed ID: 11469912)
1. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
Lane JS; Todd KE; Gloor B; Chandler CF; Kau AW; Ashley SW; Reber HA; McFadden DW
J Surg Res; 2001 Aug; 99(2):365-70. PubMed ID: 11469912
[TBL] [Abstract][Full Text] [Related]
2. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
3. Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis.
Zhao H; Chen JW; Zhou YK; Zhou XF; Li PY
World J Gastroenterol; 2003 Feb; 9(2):338-41. PubMed ID: 12532462
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Wang X; Sun Z; Börjesson A; Andersson R
Br J Surg; 1999 Mar; 86(3):411-6. PubMed ID: 10201790
[TBL] [Abstract][Full Text] [Related]
5. [The role of lipopolysacchride-binding protein in the pathogenesis of animal model of acute necrotizing pancreatitis].
Wang XP; Wu LY; Wu K; Zhang RL; Dong YW
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1619-23. PubMed ID: 14642122
[TBL] [Abstract][Full Text] [Related]
6. CO2 abdominal insufflation decreases local and systemic inflammatory response in experimental acute pancreatitis.
Machado MC; Coelho AM; Martins JO; Sampietre SN; Molan NA; Patzina RA; Machado MA; Jancar S
Pancreas; 2010 Mar; 39(2):175-81. PubMed ID: 19924017
[TBL] [Abstract][Full Text] [Related]
7. Aggravation of acute pancreatitis by heparan sulfate in mice.
Liu H; Li Y; Wang L; Chen H; Guan J; Zhou Z
Scand J Gastroenterol; 2009; 44(5):626-32. PubMed ID: 19194821
[TBL] [Abstract][Full Text] [Related]
8. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.
Abu-Zidan FM; Windsor JA
Eur J Surg; 2002; 168(4):215-9. PubMed ID: 12440758
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis.
de Campos T; Deree J; Martins JO; Loomis WH; Shenvi E; Putnam JG; Coimbra R
Pancreas; 2008 Jul; 37(1):42-9. PubMed ID: 18580443
[TBL] [Abstract][Full Text] [Related]
11. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
Hackert T; Werner J; Gebhard MM; Klar E
Surgery; 2004 Feb; 135(2):131-8. PubMed ID: 14739847
[TBL] [Abstract][Full Text] [Related]
12. The STAT4 and STAT6 pathways in pancreatitis-associated lung injury.
Simovic MO; Ballard BR; Gray KD; Stain SC
J Surg Res; 2007 Jan; 137(1):10-5. PubMed ID: 17109890
[TBL] [Abstract][Full Text] [Related]
13. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
[TBL] [Abstract][Full Text] [Related]
14. Statin pretreatment in experimental acute pancreatitis.
Almeida JL; Sampietre SN; Mendonça Coelho AM; Trindade Molan NA; Machado MC; Monteiro da Cunha JE; Jukemura J
JOP; 2008 Jul; 9(4):431-9. PubMed ID: 18648134
[TBL] [Abstract][Full Text] [Related]
15. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
[TBL] [Abstract][Full Text] [Related]
16. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
Johnson CD; Kingsnorth AN; Imrie CW; McMahon MJ; Neoptolemos JP; McKay C; Toh SK; Skaife P; Leeder PC; Wilson P; Larvin M; Curtis LD
Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic effect of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine in mice with acute necrotizing pancreatitis].
Li L; Wang XP; Wu K
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1235-9. PubMed ID: 15387956
[TBL] [Abstract][Full Text] [Related]
19. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice.
Gloor B; Todd KE; Lane JS; Rigberg DA; Reber HA
J Surg Res; 1998 Nov; 80(1):110-4. PubMed ID: 9790823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
